1. A1.72 Baricitinib, an oral janus kinase inhibitor, in the treatment of rheumatoid arthritis: safety and efficacy in an open-label, long-term extension study1. (31st January 2014) Authors: Taylor, Peter; Genovese, Mark; Keystone, Ed; Schlichting, Douglas; Beattie, Scott; Macias, William Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 1(2014) Page Start: A31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Baricitinib in rheumatoid arthritis: evidence-to-date and clinical potential. (February 2017) Authors: Kuriya, Bindee; Cohen, Marc D.; Keystone, Ed Journal: Therapeutic advances in musculoskeletal disease Issue: Volume 9:Number 2(2017) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗